Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Ambetter of Illinois offers Illinois residents a variety of affordable plans during Open Enrollment beginning Nov. 1  CHICAGO , Nov. 2, 2023 /PRNewswire/ --  Ambetter of Il linois , a product offered by a wholly owned subsidiary of Centene Corporation (NYSE: CNC) which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace, announced today that it will offer a variety of affordable health insurance plans to residents in 23 counties in Illinois for 2024. Open Enrollment for the Health Insurance Marketplace for Illinois runs from Nov. 1, 2023, through Jan. 15, 2024.

Ambetter of Illinois Expands Health Insurance Offering to 23 Counties Statewide - Offering More Residents Affordable, Accessible Coverage

Ambetter from MHS offers Indiana residents a variety of affordable plans during Open Enrollment beginning Nov. 1  INDIANAPOLIS , Nov. 2, 2023 /PRNewswire/ -- Ambetter from MHS , a product offered by a wholly owned subsidiary of Centene Corporation (NYSE: CNC), which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace, announced today that it will offer a variety of affordable health insurance plans to residents in all 92 counties in Indiana in 2024. Open enrollment for the Health Insurance Marketplace for Indiana runs from Nov. 1, 2023, through Jan. 15, 2024.

Ambetter from MHS Offers Health Insurance to All 92 Counties Across Indiana in 2024

Ambetter from Sunflower Health Plan offers Kansas residents a variety of affordable plans during Open Enrollment beginning Nov. 1 LENEXA, Kan. , Nov. 2, 2023 /PRNewswire/ --  Ambetter from Sunflower Health Plan , a product offered by a wholly owned subsidiary of Centene Corporation (NYSE: CNC), which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace, announced today that it will offer a variety of affordable health insurance plans to residents in 91 counties in Kansas for 2024.

Ambetter from Sunflower Health Plan Offers Health Insurance to 91 Counties Across Kansas in 2024

Arista Networks

Carnival

Chipotle

Catalent

Dollar General

Intel

NVIDIA

Warner Bros Discovery Inc

Zions Bancorp

The S&P 500 just dropped for the third straight month — clobbering most S&P 500 investors. But there's still plenty of ways to profit.

10 Stocks Turn $10,000 Into $158,688 In 10 Months

OMAHA, Neb.--(BUSINESS WIRE)--Mutual of Omaha, a highly rated Fortune 400 organization offering a variety of insurance and financial products for individuals, businesses and groups throughout the United States, today announced it has formed a strategic alliance with Wellcare, the Medicare Advantage brand and wholly owned subsidiary of Centene Corporation (NYSE: CNC), to offer jointly-designed Medicare Advantage plans for the 2024 plan year. These plans will be offered in Georgia, Missouri, Sout.

Mutual of Omaha and Wellcare to Offer Co-Branded Medicare Advantage Plans for 2024 Plan Year

Remains the top  marketplace carrier based on enrollment and market share since its inception in 2014  ST. LOUIS , Oct. 25, 2023 /PRNewswire/ -- Ambetter Health , the health insurance marketplace carrier of Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will expand its footprint into 83 new counties across 11 states in 2024.

Ambetter Health Marks 11th Year on Federal Healthcare Marketplace, Expands Geographic Footprint for 2024

ST. LOUIS, Oct. 24, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) , a leading healthcare enterprise committed to helping people live healthier lives, announced today that it has been named to the 2023 Fortune Best Workplaces for Women  list, ranking 67 out of 100 companies in the Large Company category. This marks the first time Centene has appeared on the annual list, which recognizes companies that demonstrate high employee-ranked scores in trust, fairness and pride among women employees.

CENTENE NAMED ONE OF THE 2023 BEST WORKPLACES FOR WOMEN™ BY FORTUNE

Centene (CNC) anticipates adjusted EPS to register a minimum of $6.60 this year.

Centene (CNC) Q3 Earnings Beat on Commercial Growth, View Raised

Centene Corporation (NYSE:CNC ) Q3 2023 Earnings Conference Call October 24, 2023 8:30 AM ET Company Participants Jennifer Gilligan - SVP, Finance & IR Sarah M. London - CEO Drew Asher - CFO Ken Fasola - President Conference Call Participants Kevin Fischbeck - Bank of America Stephen Baxter - Wells Fargo Joshua Raskin - Nephron Research Justin Lake - Wolfe Research A.J.

Centene Corporation (CNC) Q3 2023 Earnings Call Transcript

The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, Centene (CNC) Q3 Earnings: A Look at Key Metrics

Centene (CNC) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $1.30 per share a year ago.

Centene (CNC) Beats Q3 Earnings and Revenue Estimates

Albemarle

Vici Properties

Companies constantly seek innovative ways to secure their financial futures and ensure sustained value growth in the business landscape. This article delves into the strategies of three distinct companies.

Stay Ahead of the Curve: 3 Value Stocks to Secure Your Financial Future

Centene Corp beat Wall Street estimates for third-quarter profit on Tuesday, helped by lower-than-feared medical costs.

Centene's quarterly profit beats estimates

-- Diluted E PS of $0.87; Adjusted Diluted EPS of $2.00 -- -- Increases 2023 Full Year Guidance -- Adjusted diluted EPS of $2.00 , up over 53% from $1.30 in the third quarter of 2022. Increases 2023 full year adjusted diluted EPS guidance by $0.15 to at least $6.60; reiterates 2024 adjusted diluted EPS floor of greater than $6.60.

CENTENE CORPORATION REPORTS THIRD QUARTER 2023 RESULTS

ST. LOUIS , Oct. 23, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("the Company"), a leading healthcare enterprise committed to helping people live healthier lives, announced today it has named Wade Rakes its Chief Growth Officer. Mr. Rakes, who currently serves as Plan President and Chief Executive Officer of Centene's Georgia-based subsidiary, Peach State Health Plan ("Peach State"), will leverage his extensive Medicaid, business development and health plan leadership experience to support and advance the Company's uniquely local business model in collaboration with Centene's health plans and lines of business.

CENTENE CORPORATION ANNOUNCES NEW CHIEF GROWTH OFFICER

Centene's (CNC) third-quarter results are likely to reflect higher premiums and lower cost of services.

Can Centene's (CNC) Q3 Earnings Beat on Membership Growth?

Centene (CNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Centene (CNC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Robust revenue growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.

Here's Why You Should Hold Centene (CNC) in Your Portfolio

Centene (CNC) declares the availability of a varied set of health plans across new counties in 2024. It, thereby, places intensified focus on growing its Medicare business.

Centene (CNC) Eyes Membership Growth With 2024 Expansion Plans

Amgen

UnitedHealth Group

Over the last several months, many sectors, industries, and the overall market have come under pressure and experienced significant outflows and waves of selling.

Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks

Wellcare will offer 23 newly designed plans as well as new Dual Eligible Special Needs Plans, accepting all dual eligible beneficiaries New in 2024, Wellcare Spendables™ debit card will allow pre-loaded funds to be used across 55,000 nationwide retailers in 37 states Wellcare to offer Medicare Advantage plans to 37 states and 102 Prescription Drug Plans nationwide TAMPA, Fla. , Oct. 11, 2023 /PRNewswire/ -- Wellcare, the Medicare brand and wholly owned subsidiary of Centene Corporation (NYSE: CNC), announced today it will expand its wide range of Medicare Advantage (MA) and Medicare Prescription Drug Plan (PDP) offerings during the 2024 Medicare Annual Enrollment Period (AEP), beginning Oct. 15, 2023.

Wellcare's Expanded 2024 Medicare Advantage and Medicare Prescription Drug Plan Offerings Bring Enhanced Value and Affordability to Members

Centene serves the underinsured and uninsured in the U.S. healthcare sector, filling a significant market gap. CNC operates through two main segments: Managed Care and Specialty Services, catering to over 26 million members. The company has commendable lobbying efforts. However, it faces challenges, including political dynamics, Medicare Advantage Star Ratings, and the potential impacts of the 2024 elections.

Decoding Centene: Why I Think It's Undervalued

ST. LOUIS , Oct. 3, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise that is committed to helping people live healthier lives, announced that it will release its 2023 third quarter financial results at approximately 6 a.m. EDT on Tuesday, October 24, 2023, and will host a conference call afterwards at approximately 8:30 a.m.

CENTENE CORPORATION SCHEDULES 2023 THIRD QUARTER FINANCIAL RESULTS CONFERENCE CALL

CF Industries Holdings

Charter Communications

SPDR S&P 500 ETF Trust

Valero Energy

WestRock

The S&P 500 witnessed its worst month of 2023, losing 5% in September. Fears of higher rates for a longer-than-expected period took the sheen away from stocks in the month.

S&P 500 Logs Worst Month of 2023: 5 Stocks Still Up in ETF

Cosmos Holdings

iBio

The healthcare industry has historically provided significant returns to investors. And, it is currently boasting a compounding annual growth rate prediction of 10.4% until 2027.

News for Centene Stock (CNC)